AtriCure (ATRC) Non-Current Assets (2010 - 2026)
AtriCure's (ATRC) quarterly Non-Current Assets came in at $330.3 million in Q1 2026, down 2.9% year-on-year from $340.1 million in Q1 2025, and little changed on a QoQ basis from $331.7 million in Q4 2025.
AtriCure (ATRC) Non-Current Assets (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has 17 years of Non-Current Assets data on file, last reported at $330.3 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 2.9% year-over-year to $330.3 million in Q1 2026; TTM through Mar 2026 was $1.3 billion, a 2.77% decrease from a year earlier, with the FY2025 full-year figure at $331.7 million, down 2.88% from the prior year.
- Non-Current Assets for Q1 2026 stood at $330.3 million, roughly flat from $331.7 million in the prior quarter.
- Over the last five years, Non-Current Assets for ATRC reached as high as $385.4 million in Q1 2022 and fell as low as $330.3 million in Q1 2026.
- Historically, Non-Current Assets has averaged $350.3 million across 5 years, with a median of $345.8 million in 2024.
- Across the five-year window, Non-Current Assets dropped 18.04% in 2022 and gained 0.47% in 2024, its largest moves.
- Year by year, Non-Current Assets stood at $370.2 million in 2022, then slipped by 6.09% to $347.7 million in 2023, then dropped by 1.78% to $341.5 million in 2024, then dropped by 2.88% to $331.7 million in 2025, then decreased by 0.41% to $330.3 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $330.3 million in Q1 2026, $331.7 million in Q4 2025, and $334.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | AtriCure | 1.60 Bn | 1.45 Bn | 109.31 Mn | 330.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 330.30 Mn |
| Dec 31, 2025 | 331.66 Mn |
| Sep 30, 2025 | 334.33 Mn |
| Jun 30, 2025 | 337.59 Mn |
| Mar 31, 2025 | 340.15 Mn |
| Dec 31, 2024 | 341.50 Mn |
| Sep 30, 2024 | 345.78 Mn |
| Jun 30, 2024 | 344.42 Mn |
| Mar 31, 2024 | 346.40 Mn |
| Dec 31, 2023 | 347.69 Mn |
| Sep 30, 2023 | 347.55 Mn |
| Jun 30, 2023 | 356.20 Mn |
| Mar 31, 2023 | 344.78 Mn |
| Dec 31, 2022 | 370.23 Mn |
| Sep 30, 2022 | 369.63 Mn |
| Jun 30, 2022 | 381.22 Mn |
| Mar 31, 2022 | 385.38 Mn |
| Dec 31, 2021 | 419.24 Mn |
| Sep 30, 2021 | 417.26 Mn |
| Jun 30, 2021 | 465.13 Mn |